Culture of yellowtail Seriola quinqueradiata accounts for most of the production of Japanese marine fish farms. As with any intensively cultured fish, fish disease is a major problem. Thus, treatment of cultured yellowtail with antibiotics against bacterial infection is essential for profitability.1) In particular, enterococcicosis, a bacterial infection that was first observed in yellowtail in Japan in 1974,2) accounted for 67.9% of the losses of cultured yel lowtail in 1991. 1) Macrolides such as erythromycin (EM) and spiramycin (SP), and lincomycin (LCM) have been used as chemother apeutic agents for the treatment of enterococcicosis.3-6) However, in recent years, these antibiotics have become in effective against Enterococcus seriolicida (syn. Lactococ cus garvieae) ,7) the bacterium causing this disease. Their extensive uses have led to an increase in multiple drug resistant strains of E. seriolicida8-10) Therefore, the development of a new drug having a different mechanism of drug action from that of macro fides has been awaited. On the other hand, there have been scarcely any reports on the use of penicillins, which are effective against gram-positive organisms , for the treat ment of enterococcicosis .11,12) The only exception is a report on the drug sensitivity of E . seriolicida isolated be tween 1974 and 1981 by Aoki et al . 13 ) Penicillins, such as penicillin G (PCG) and methicillin, are given parenterally. 
Fish
The yellowtail used in this study were reared at Tsukuba Research Laboratories of Fujisawa Pharmaceutical Co., Ltd. These fish had not been treated with any antibiotics for at least 4 weeks prior to the study. 
Discussion
Penicillins are widely used for the treatment of bacterial infection in humans and livestock but not in fish. 19, 20) The only penicillins used in fish are ABPC and amoxicillin, which are used for the treatment of pseudotuberculosis in yellowtail.21) Penicillins have not been actively used for the treatment of diseases in fish because, in general, they are unstable in heat and acid, and because the desired level can not be ob tained by practical oral route.14)
Since the antibacterial activity of penicillins against or ganisms is exerted by inhibiting biosynthesis of the bacteri al cell walls, these drugs are very safe and are more active against gram-positive organisms than gram-negative organ isms. Therefore, these drugs are expected to be effective against enterococcicosis from the viewpoint of their bac tericidal activity.
In the present study, we found that the decomposition of PCG at pH 3 (which is equivalent to the pH of gastric acid), was faster than that of its derivative, TBPC. The retention time of feed in the stomach is not clear, but in our study, 80% or more of the TBPC, even at pH 3, was retained 6 h after administration.
The AUC between 0 and 10 h of TBPC after administra tion was about 7 times greater than that of PCG.
From the results of the stability of TBPC and PCG in the acidic solution and the blood concentration of PCG in yellowtail after oral administration, TBPC appears to have a greater resistance to gastric acid than PCG.
The drug sensitivities of E. seriolicida isolated from five areas of Japan between 1992 and 1996 were determined. There were strains resistant to EM, LCM and OTC, but the MICs of PCG or ABPC were concentrated in a narrow range. None of the strains were resistant to PCG or ABPC.
Since PCG is the same kind of drug as ABPC, the pos sibility of development of cross-resistance was considered. However, since no resistance to these drugs was observed in the present survey, the resistance of E. seriolicida to penicillins appeared to be very low because of the differ ence of the season when pseudotuberculosis and enterococ cicosis are most prevalent.
It was shown that PCG concentrations sufficient to in hibit the growth of E. seriolicida can be maintained for several hours after oral administration of TBPC. Further more, a preliminary clinical study of TBPC in enterococci cosis-affected yellowtail appears to show that TBPC has an antibacterial activity against E. seriolicida.
The present results suggest that TBPC has promise as a drug for treating enterococcicosis and that further investi gations will be worthwhile. We have recently found that TBPC has an excellent field efficacy to natural infection of E. seriolicida in yellowtail and will report these results in a subsequent paper.
